Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMarlowe Regulatory News (MRL)

  • This share is currently suspended. It was suspended at a price of 440.00
  • There is currently no data for MRL

Refinance and Acquisition Completion

14 Oct 2021 07:00

RNS Number : 0055P
Marlowe PLC
14 October 2021
 

14 October 2021

 

Marlowe plc

 

Refinance and Acquisition Completion

 

Marlowe plc ("Marlowe" or the "Group"), the UK leader in business-critical services and software which assure safety and regulatory compliance, announces that it has increased its finance facility with HSBC Bank PLC and National Westminster Bank PLC. Total facilities have been increased from £90m to £130m and will provide further resources to support the Group's M&A strategy.

 

In addition, and further to the Company's announcement of 4 October 2021, the Group confirms that the Acquisition of Hydro-X Group Ltd has now completed.

 

 

 

 

For further information:

 

Marlowe plc

www.marloweplc.com

 

 

 

Alex Dacre, Chief Executive

Tel: +44 (0) 203 813 8498

 

 

 

Adam Councell, Chief Financial Officer

Julian Wais, Head of Investor Relations

IR@marloweplc.com

 

 

 

 

 

 

Cenkos Securities plc (Nominated Adviser and Joint Broker)

 

 

 

Nicholas Wells

Tel: +44 (0)20 7397 8900

 

 

Ben Jeynes

George Lawson

 

 

 

 

 

 

 

Berenberg (Joint Broker)

 

 

 

Ben Wright

Mark Whitmore

Tel: +44 (0)20 3207 7800

 

 

 

 

 

 

FTI Consulting

 

 

Nick Hasell

Alex Le May

Tel: +44 (0)20 3727 1340

 

 

 

 

 

 

About Marlowe plc

Marlowe is a UK leader in business-critical services and software which assure safety and regulatory compliance. The company was formed to create sustainable shareholder value through the acquisition and development of businesses that provide regulated safety and compliance services and software. It is focused on compliance software, eLearning, health & safety, employment law & HR compliance, fire safety & security, water & air hygiene and occupational health services - all of which are vital to the wellbeing of its customers operations and are invariably governed by regulation. Marlowe currently provides software to over 1 million users and services to over 25% of Britain's commercial premises. The Group provides customers with a single outsourced, nationwide, provider of a range of regulated compliance and safety solutions. Our customers can be found in office complexes, high streets & leisure facilities, manufacturing plants and industrial estates, and include thousands of SMEs, local authorities, facilities management providers, multi-site NHS trusts and FTSE 100 companies.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ACQGPGRPUUPGGQW
Date   Source Headline
4th Jul 202512:26 pmRNSForm 8.3 - Mitie Group Plc
4th Jul 202512:00 pmRNSForm 8.5 (EPT/RI) Marlowe Plc
4th Jul 202512:00 pmRNSForm 8.5 (EPT/RI) - Mitie Group Plc
4th Jul 202511:46 amRNSForm 8.5 (EPT/RI)
4th Jul 202510:17 amRNSHolding(s) in Company
4th Jul 20259:41 amRNSForm 8.5 (EPT/NON-RI)
4th Jul 20257:00 amRNSHolding(s) in Company
3rd Jul 20253:25 pmBUSForm 8.3 - Marlowe plc
3rd Jul 20252:51 pmRNSForm 8.3 MARLOWE PLC
3rd Jul 20252:20 pmRNSForm 8.3 - Mitie Group Plc
3rd Jul 20251:52 pmGNWForm 8.3 - Marlowe plc - Octopus Investments
3rd Jul 20251:46 pmRNSForm 8.3 - Mitie Group Plc - Replacement
3rd Jul 20251:14 pmRNSForm 8.3 - Mitie Group plc
3rd Jul 202512:23 pmGNWForm 8.3 - [MARLOWE PLC - 02 07 2025] - (CGWL)
3rd Jul 202512:00 pmRNSForm 8.5 (EPT/RI) Marlowe Plc
3rd Jul 202512:00 pmRNSForm 8.5 (EPT/RI) - Marlowe Plc
3rd Jul 202511:53 amRNSForm 8.5 (EPT/RI)
3rd Jul 202510:35 amRNSForm 8.5 (EPT/NON-RI)
3rd Jul 202510:22 amRNSHolding(s) in Company
3rd Jul 20259:21 amRNSForm 8.3 - Marlowe PLC
3rd Jul 20257:01 amRNSForm 8 (DD) - Mitie Group plc
3rd Jul 20257:00 amRNSPublication of Annual Report
2nd Jul 20253:15 pmRNSForm 8.3 MARLOWE PLC
2nd Jul 20253:03 pmRNSForm 8.3 - Mitie Group Plc
2nd Jul 20252:55 pmGNWForm 8.3 - [MARLOWE PLC - 01 07 2025] - (CGWL)
2nd Jul 20252:51 pmGNWForm 8.3 - [MARLOWE PLC - 30 06 2025] - (CGWL)
2nd Jul 20252:13 pmBUSForm 8.3 - Marlowe PLC
2nd Jul 20251:56 pmGNWForm 8.3 - Marlowe plc - Octopus Investments
2nd Jul 202512:42 pmRNSForm 8.3 - MITIE GROUP PLC
2nd Jul 202512:00 pmRNSForm 8.5 (EPT/RI) Marlowe Plc
2nd Jul 202512:00 pmRNSForm 8.5 (EPT/RI) - Mitie Group Plc
2nd Jul 202512:00 pmRNSForm 8.5 (EPT/RI) - Marlowe Plc
2nd Jul 202511:57 amRNSForm 8.5 (EPT/RI) - Marlowe PLC
2nd Jul 202511:33 amGNWForm 8.3 - Marlowe Plc
2nd Jul 20257:00 amRNSForm 8 (DD) - Mitie Group plc
1st Jul 20253:22 pmRNSForm 8 (DD) - Mitie Group plc
1st Jul 20252:57 pmRNSForm 8.3 MARLOWE PLC
1st Jul 20252:55 pmGNWForm 8.3 - Marlowe plc - Octopus Investments
1st Jul 20252:12 pmBUSForm 8.3 - Marlowe PLC
1st Jul 20251:51 pmRNSForm 8.3 - Mitie Group Plc
1st Jul 20251:23 pmRNSForm 8.5 (EPT/RI) - Marlowe PLC
1st Jul 202512:55 pmRNSForm 8.3 - MITIE GROUP PLC
1st Jul 202512:30 pmRNSHolding(s) in Company
1st Jul 202512:00 pmRNSForm 8.5 (EPT/RI) Marlowe Plc
1st Jul 202512:00 pmRNSForm 8.5 (EPT/RI) - Mitie Group Plc
1st Jul 202510:16 amRNSForm 8.5 (EPT/NON-RI)
30th Jun 20252:53 pmBUSForm 8.3 - Marlowe PLC
30th Jun 20252:42 pmRNSForm 8.3 - MITIE GROUP PLC
30th Jun 20252:16 pmRNSForm 8.3 - Marlowe PLC
30th Jun 20251:49 pmGNWForm 8.3 - Marlowe Plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.